{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:56:03Z","timestamp":1787950563636,"version":"build-2784847793"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1898-z","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T10:50:55Z","timestamp":1476960655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Increasing incidence associated with herpes zoster infection in British Columbia, Canada"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1266-1901","authenticated-orcid":false,"given":"Fawziah","family":"Marra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Najafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"issue":"4","key":"1898_CR1","doi-asserted-by":"publisher","first-page":"222e30","DOI":"10.1097\/00013542-199310000-00006","volume":"4","author":"E Miller","year":"1993","unstructured":"Miller E, Marshall R, Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol. 1993;4(4):222e30.","journal-title":"Rev Med Microbiol"},{"issue":"9544","key":"1898_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365\u201376.","journal-title":"Lancet"},{"key":"1898_CR3","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9\u201320.","journal-title":"Proc R Soc Med"},{"issue":"3","key":"1898_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen JI. Clinical practice: Herpes zoster 2. N Engl J Med. 2013;369(3):255\u201363.","journal-title":"N Engl J Med"},{"issue":"2","key":"1898_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF00916011","volume":"7","author":"AR Hayward","year":"1987","unstructured":"Hayward AR, Herberger M. Lymphocyte responses to varicella zoster virus in the elderly. J Clin Immunol. 1987;7(2):174\u20138.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1898_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/infdis\/171.3.701","volume":"171","author":"K Schmader","year":"1995","unstructured":"Schmader K, George LK, Burchett BM, Pieper CF, Hamilton JD. Racial differences in the occurrence of herpes zoster. J Infect Dis. 1995;171(3):701\u20134.","journal-title":"J Infect Dis"},{"key":"1898_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annepidem.2005.12.002","volume":"16","author":"W Opstelten","year":"2006","unstructured":"Opstelten W, van Essen GA, Schellevis F, Verheij TJ, Moons KG. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol. 2006;16:692\u20135.","journal-title":"Ann Epidemiol"},{"key":"1898_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","volume":"360","author":"SL Thomas","year":"2002","unstructured":"Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case\u2013control study. Lancet. 2002;360:678\u201382.","journal-title":"Lancet"},{"key":"1898_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1017\/CBO9780511601194.015","volume-title":"Varicella-Zoster Virus: Virology and Clinical Management","author":"MN Oxman","year":"2000","unstructured":"Oxman MN. Clinical manifestations of herpes zoster. In: Arvin AM, Gershon AA, editors. Varicella-Zoster Virus: Virology and Clinical Management. Cambridge: Cambridge University Press; 2000. p. 246\u201375."},{"issue":"1","key":"1898_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJM199607043350107","volume":"335","author":"RG Kost","year":"1996","unstructured":"Kost RG, Straus SE. Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med. 1996;335(1):32\u201342.","journal-title":"N Engl J Med"},{"issue":"suppl","key":"1898_CR11","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jpain.2007.10.008","volume":"91","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Gnann Jr JW, Oaklander AL, et al. Diagnosis and assessment of pain associated with herpes zoster or post-herpectic neuralgia. J Pain. 2008;91(suppl):S37\u201344.","journal-title":"J Pain"},{"key":"1898_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2334-13-170","volume":"13","author":"S Pinchinat","year":"2013","unstructured":"Pinchinat S, Cebrian-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13:170.","journal-title":"BMC Infect Dis"},{"key":"1898_CR13","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833.","journal-title":"BMJ Open"},{"key":"1898_CR14","unstructured":"Schmader KE, Oxman MN. Chapter 194. Varicella and Herpes Zoster. In: Goldsmith LA, Katz SI, Gilchrest BA et al., editors. Fitzpatrick\u2019s Dermatology in General Medicine. New York: McGraw-Hill; 2012."},{"key":"1898_CR15","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2105\/AJPH.2009.160002","volume":"100","author":"JG Donahue","year":"2010","unstructured":"Donahue JG, Kieke BA, Gargiullo PM, et al. Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. Am J Public Health. 2010;100:1116\u201322.","journal-title":"Am J Public Health"},{"key":"1898_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","volume":"4","author":"SL Thomas","year":"2004","unstructured":"Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26\u201333.","journal-title":"Lancet Infect Dis"},{"key":"1898_CR17","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","volume":"20","author":"M Brisson","year":"2002","unstructured":"Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: Implications for mass vaccination against chickenpox. Vaccine. 2002;20:2500\u20137.","journal-title":"Vaccine"},{"issue":"19","key":"1898_CR18","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","volume":"28","author":"M Brisson","year":"2010","unstructured":"Brisson M, Melkonyan G, Drolet M, De SG, Thibeault R, De WP. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine. 2010;28(19):3385\u201397.","journal-title":"Vaccine"},{"issue":"5","key":"1898_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMcp013211","volume":"347","author":"JW Gnann Jr","year":"2002","unstructured":"Gnann Jr JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347(5):340\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"1898_CR20","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1017\/S0950268807007893","volume":"135","author":"ML Russell","year":"2007","unstructured":"Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect. 2007;135(6):908\u201313.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"1898_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1017\/S0950268801005921","volume":"127","author":"M Brisson","year":"2001","unstructured":"Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127(2):305\u201314.","journal-title":"Epidemiol Infect"},{"key":"1898_CR22","unstructured":"British Columbia Ministry of Health [creator] (2013): Medical Services Plan (MSP) Payment Information File. Population Data BC [publisher]. Data Extract. MOH (2013). http:\/\/www.popdata.bc.ca\/data . Accessed 26 Mar 2015."},{"key":"1898_CR23","unstructured":"British Columbia Ministry of Health [creator] (2013): Discharge Abstract Database (Hospital Separations). Population Data BC [publisher]. Data Extract. MOH (2013). http:\/\/www.popdata.bc.ca\/data (accessed 26 Mar, 2015)."},{"key":"1898_CR24","unstructured":"BC Ministry of Health [creator] (2013): PharmaNet. BC Ministry of Health [publisher]. Data Extract. Data Stewardship Committee (2013). http:\/\/www.popdata.bc.ca\/data (accessed 26 Mar 2015)."},{"key":"1898_CR25","first-page":"43","volume":"308","author":"J Zhang","year":"2012","unstructured":"Zhang J, Xie F, Delzell E, Chen L, Winthrop KL, Lewis JD, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA. 2012;308:43\u20139.","journal-title":"JAMA"},{"issue":"12","key":"1898_CR26","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4065\/mcp.2011.0305","volume":"86","author":"M Klompas","year":"2011","unstructured":"Klompas M, Kulldorff M, Vilk Y, Bialek SR, Harpaz R. Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc. 2011;86(12):1146\u201353.","journal-title":"Mayo Clin Proc"},{"key":"1898_CR27","unstructured":"BC Centre for Disease Control. New immunization programs in 2004 and 2005. BCMA 2005;47:195. Available from: http:\/\/www.bcmj.org\/bc-centre-disease-control\/new-immunization-programs-2004-and-2005 . Accessed 26 Mar 2015."},{"key":"1898_CR28","unstructured":"BC Centre for Disease Control. Two dose varicella immunization program in BC, 2012. Available from: http:\/\/www.bccdc.ca\/health-professionals\/clinical-resources\/communicable-disease-control-manual\/immunization . Accessed 26 Mar 2015."},{"issue":"22","key":"1898_CR29","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"M Oxman","year":"2005","unstructured":"Oxman M, Levin M, Johnson G, Schmader K, Straus S, Gelb L, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271\u201384.","journal-title":"N Engl J Med"},{"key":"1898_CR30","first-page":"1","volume":"36","author":"National Advisory Committee on Immunization (NACI)","year":"2010","unstructured":"National Advisory Committee on Immunization (NACI). Statement on the recommended use of herpes zoster vaccine. Can Commun Dis Rep. 2010;36:1\u201319.","journal-title":"Can Commun Dis Rep"},{"key":"1898_CR31","volume-title":"SAS Online Doc. Version 9.1","author":"SAS Institute Inc","year":"2004","unstructured":"SAS Institute Inc. SAS Online Doc. Version 9.1. Cary: SAS Institute Inc; 2004."},{"key":"1898_CR32","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20:748\u201353.","journal-title":"J Gen Intern Med"},{"key":"1898_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268803001523","volume":"132","author":"DM Fleming","year":"2004","unstructured":"Fleming DM, Cross KW, Cobb WA, Chapman RS. Gender difference in the incidence of shingles. Epidemiol Infect. 2004;132:1\u20135.","journal-title":"Epidemiol Infect"},{"key":"1898_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1017\/S0950268808000678","volume":"137","author":"A Gauthier","year":"2009","unstructured":"Gauthier A, Breuer J, Carrington D, Martin M, Re\u2019my V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137:38\u201347.","journal-title":"Epidemiol Infect"},{"issue":"47","key":"1898_CR35","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","volume":"29","author":"P Tanuseputro","year":"2011","unstructured":"Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011;29(47):8580\u20134.","journal-title":"Vaccine"},{"issue":"47","key":"1898_CR36","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1016\/j.vaccine.2013.09.018","volume":"32","author":"ML Russell","year":"2014","unstructured":"Russell ML, Dover DC, Simmonds KA, Svenson LW. Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine. 2014;32(47):6319\u201324.","journal-title":"Vaccine"},{"key":"1898_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","volume":"61","author":"MW Ragozzino","year":"1982","unstructured":"Ragozzino MW, Melton LJ, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310\u20136.","journal-title":"Medicine (Baltimore)"},{"key":"1898_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","volume":"155","author":"JG Donahue","year":"1995","unstructured":"Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med. 1995;155:1605\u20139.","journal-title":"Arch Intern Med"},{"issue":"11","key":"1898_CR39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341\u20139.","journal-title":"Mayo Clin Proc"},{"key":"1898_CR40","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1086\/651078","volume":"50","author":"D Rimland","year":"2010","unstructured":"Rimland D, Moanna A. Increasing incidence of herpes zoster among veterans. Clin Infect Dis. 2010;50:1000\u20135.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1898_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"J Leung","year":"2011","unstructured":"Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52(3):332\u201340.","journal-title":"Clin Infect Dis"},{"key":"1898_CR42","unstructured":"BC Centre for Disease Control. Immunization coverage in British Columbia. Available from: http:\/\/www.bccdc.ca\/health-info\/immunization-vaccines\/immunization-coverage . Accessed 7 Mar 2016."},{"key":"1898_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2458-5-68","volume":"5","author":"WK Yih","year":"2005","unstructured":"Yih WK, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998\u20132003. BMC Public Health. 2005;5:68.","journal-title":"BMC Public Health"},{"issue":"12","key":"1898_CR44","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1086\/591975","volume":"29","author":"MS Patel","year":"2008","unstructured":"Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol. 2008;29(12):1157\u201363.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1898_CR45","doi-asserted-by":"publisher","first-page":"739","DOI":"10.7326\/0003-4819-159-11-201312030-00006","volume":"159","author":"CM Hales Hales","year":"2013","unstructured":"Hales Hales CM, Harpaz R, Joesoef MR, et al. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013;159:739\u201345.","journal-title":"Ann Intern Med"},{"key":"1898_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5694\/j.1326-5377.2010.tb03818.x","volume":"193","author":"MR Nelson","year":"2010","unstructured":"Nelson MR, Britt HC, Harrison CM. Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine. Med J Aust. 2010;193:110\u20133.","journal-title":"Med J Aust"},{"key":"1898_CR47","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/jmv.21599","volume":"81","author":"N Toyama","year":"2009","unstructured":"Toyama N, Shiraki K. Society of the Miyazaki Prefecture Dermatologists. Epidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol. 2009;81:2053\u20138.","journal-title":"J Med Virol"},{"key":"1898_CR48","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1017\/S0950268811001786","volume":"140","author":"DY Chao","year":"2012","unstructured":"Chao DY, Chien YZ, Yeh YP, et al. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000\u20132008. Epidemiol Infect. 2012;140:1131\u201340.","journal-title":"Epidemiol Infect"},{"key":"1898_CR49","doi-asserted-by":"publisher","first-page":"e77709","DOI":"10.1371\/journal.pone.0077709","volume":"8","author":"PY Wu","year":"2013","unstructured":"Wu PY, Wu HD, Chou TC, et al. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PLoS One. 2013;8:e77709.","journal-title":"PLoS One"},{"key":"1898_CR50","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","volume":"14","author":"B Ultsch","year":"2013","unstructured":"Ultsch B, K\u00f6ster I, Reinhold T, et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ. 2013;14:1015\u201326.","journal-title":"Eur J Health Econ"},{"key":"1898_CR51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","volume":"19","author":"W Opstelten","year":"2002","unstructured":"Opstelten W, Mauritz JW, de Wit NJ, et al. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19:471\u20135.","journal-title":"Fam Pract"},{"key":"1898_CR52","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1471-2334-10-230","volume":"10","author":"LE Gialloreti","year":"2010","unstructured":"Gialloreti LE, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 4","key":"1898_CR53","first-page":"193","volume":"151","author":"J Schiffner-Rohe","year":"2010","unstructured":"Schiffner-Rohe J, Jow S, Lilie HM, et al. Herpes zoster in Germany. A retrospective analyse of SHL data. MMW Fortschr Med. 2010;151 Suppl 4:193\u20137.","journal-title":"MMW Fortschr Med"},{"issue":"1","key":"1898_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","volume":"157","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, Langan SM. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157(1):30\u201354.","journal-title":"Pain"},{"key":"1898_CR55","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1086\/591132","volume":"47","author":"LA Jackson","year":"2008","unstructured":"Jackson LA, Reynolds MA, Harpaz R. Hospitalizations to treat herpes zoster in older adults: causes and validated rates. Clin Infect Dis. 2008;47:754\u20139.","journal-title":"Clin Infect Dis"},{"key":"1898_CR56","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","volume":"27","author":"AN Stein","year":"2009","unstructured":"Stein AN, Britt H, Harrison C, et al. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50\u00a0years and older. Vaccine. 2009;27:520\u20139.","journal-title":"Vaccine"},{"key":"1898_CR57","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","volume":"70","author":"K Hillebrand","year":"2015","unstructured":"Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005\u20132009. J Infect. 2015;70:178\u201386.","journal-title":"J Infect"},{"issue":"1","key":"1898_CR58","doi-asserted-by":"publisher","first-page":"62e9","DOI":"10.1086\/320884","volume":"33","author":"C Chidiac","year":"2001","unstructured":"Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplege A, et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis. 2001;33(1):62e9.","journal-title":"Clin Infect Dis"},{"key":"1898_CR59","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1136\/annrheumdis-2015-207841","volume":"74","author":"KL Winthrop","year":"2015","unstructured":"Winthrop KL, Novosad SA, Baddley JW, Calabrese L, Chiller T, Polgreen P, et al. Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance. Ann Rheum Dis. 2015;74:2107\u201316.","journal-title":"Ann Rheum Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1898-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T20:53:09Z","timestamp":1657486389000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1898-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1898"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1898-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]},"article-number":"589"}}